Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3247675
Max Phase: Preclinical
Molecular Formula: C55H87N13O13
Molecular Weight: 1138.38
Molecule Type: Small molecule
Associated Items:
ID: ALA3247675
Max Phase: Preclinical
Molecular Formula: C55H87N13O13
Molecular Weight: 1138.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C
Standard InChI: InChI=1S/C55H87N13O13/c1-8-10-11-12-13-18-43(70)61-39(28-44(71)72)48(74)62-37(16-14-23-59-55(56)57)47(73)66-45(32(5)6)51(77)63-38(26-34-19-21-36(69)22-20-34)49(75)67-46(33(7)9-2)52(78)64-40(27-35-29-58-30-60-35)53(79)68-24-15-17-42(68)50(76)65-41(54(80)81)25-31(3)4/h19-22,29-33,37-42,45-46,69H,8-18,23-28H2,1-7H3,(H,58,60)(H,61,70)(H,62,74)(H,63,77)(H,64,78)(H,65,76)(H,66,73)(H,67,75)(H,71,72)(H,80,81)(H4,56,57,59)/t33-,37-,38-,39-,40-,41-,42-,45-,46-/m0/s1
Standard InChI Key: VCAJIGABFIUMLA-FHQRKWARSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1138.38 | Molecular Weight (Monoisotopic): 1137.6546 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Paiva AC, Nouailhetas VL, Paiva TB.. (1977) Synthesis of octanoyl[8-leucyl]angiotensin II, a lipophilic angiotensin antagonist., 20 (7): [PMID:874965] [10.1021/jm00217a006] |
Source(1):